Related Experiment Video

Updated: Jul 11, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment

Piero Marchetti1, Francesco Dotta, Davide Lauro

  • 1Department of Endocrinology and Metabolism, Metabolic Unit, University of Pisa, Pisa, Italy. marchant@immr.med.unipi.it

Regulatory Peptides
|September 25, 2007
PubMed

Insights

Type 2 diabetes involves impaired beta-cell function and insulin sensitivity. Research highlights the beta-cell

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cell Biology

Background:

  • Type 2 diabetes (T2D) is a prevalent metabolic disorder.
  • It stems from impaired beta-cell function and insulin sensitivity.
  • The beta-cell's role in T2D development and progression is increasingly recognized.

Purpose of the Study:

  • To review the central role of the beta-cell in Type 2 diabetes.
  • To discuss genetic and acquired factors affecting beta-cell function.
  • To explore potential therapeutic interventions targeting beta-cell defects.

Main Methods:

  • Literature review of studies on Type 2 diabetes and beta-cell function.
  • Analysis of research on genetic polymorphisms and environmental factors impacting islets.
  • Examination of in vitro studies on pharmacological interventions for beta-cell defects.

Main Results:

  • Reduced islet and/or beta-cell mass/volume is reported in T2D.
  • Isolated T2D islets exhibit quantitative and qualitative defects in insulin secretion.
  • Genotype, glucotoxicity, lipotoxicity, and altered IAPP processing are key factors.
  • Pharmacological interventions show promise in improving T2D islet cell function in vitro.

Conclusions:

  • The beta-cell is critically involved in the pathogenesis of Type 2 diabetes.
  • Both genetic predisposition and acquired factors contribute to beta-cell dysfunction.
  • Therapeutic strategies aimed at improving beta-cell function may offer a non-relentless disease progression.

More Related Videos

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice06:57

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice

Published on: April 10, 2026

Staining Protocols for Human Pancreatic Islets07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...